KRAS mutations often occur simultaneously with tumor protein p53 in pancreatic ductal adenocarcinoma, Kelch-like ECH-associated protein 1 in non-small cell lung cancer, and PIK3CA mutation in colorectal cancer [31]. Here, TP53 is linked to non-small cell lung carcinoma.